Non-coding RNA Research (Dec 2024)

Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics

  • Sahreen Sumaira,
  • Soundararajan Vijayarathna,
  • Manisekaran Hemagirri,
  • Mohd Adnan,
  • Md Imtaiyaz Hassan,
  • Mitesh Patel,
  • Reena Gupta,
  • Shanmugapriya,
  • Yeng Chen,
  • Subash C.B. Gopinath,
  • Jagat R. Kanwar,
  • Sreenivasan Sasidharan

Journal volume & issue
Vol. 9, no. 4
pp. 1140 – 1158

Abstract

Read online

Irrespective of medical technology improvements, cancer ranks among the leading causes of mortality worldwide. Although numerous cures and treatments exist, creating alternative cancer therapies with fewer adverse side effects is vital. Since ancient times, plant bioactive compounds have already been used as a remedy to heal cancer. These plant bioactive compounds and their anticancer activity can also deregulate the microRNAs (miRNAs) in the cancerous cells. Therefore, the deregulation of miRNAs in cancer cells by plant bioactive compounds and the usage of the related miRNA could be a promising approach for cancer cure, mainly to prevent cancer and overcome chemotherapeutic side effect problems. Hence, this review highlights the function of plant bioactive compounds as an anticancer agent through the underlying mechanism that alters the miRNA expression in cancer cells, ultimately leading to apoptosis. Moreover, this review provides insight into using plant bioactive compounds -driven miRNAs as an anticancer agent to develop miRNA-based cancer gene therapy. They can be the potential resource for gene therapy and novel strategies targeting cancer therapeutics.

Keywords